High potassium on a blood test is not a typical early warning sign of cancer, but it can show up in people who already have cancer for several distinct reasons. Tumors can damage kidneys, invade adrenal glands, or spill their cellular contents into the bloodstream, all of which can push potassium levels above normal. One large prospective study of healthy men even found that those with elevated potassium at baseline had a roughly 40 percent higher rate of cancer diagnoses over the following decades, though that finding raises more questions than it answers. The relationship between potassium and cancer is real, but it is tangled, and what it means for any individual depends heavily on context.
Why Cancer Patients Develop High Potassium
Potassium is the most abundant positively charged ion inside your cells. Blood levels stay tightly regulated in a narrow range, and when they climb above about 5.5 milliequivalents per liter, doctors call it hyperkalemia. In cancer patients, this happens through a handful of mechanisms that often overlap.1IntechOpen. Potassium in Solid Cancers The two broadest categories are reduced kidney excretion and a flood of potassium escaping from dying tumor cells.2Oncology in Clinical Practice. Potassium imbalances induced by systemic cancer therapy: pathophysiology and potential therapeutic strategies A third, less common pathway involves cancer disrupting the hormones that normally help the kidneys regulate potassium.
None of these mechanisms is unique to cancer. Kidney disease from diabetes, certain blood pressure medications, and even severe dehydration can all cause high potassium. So an abnormal reading on a routine blood panel is far more likely to reflect one of these everyday causes than an undiagnosed malignancy. That said, when high potassium does occur in a cancer context, it tends to be more severe, harder to treat, and more dangerous.
Tumor Lysis Syndrome
The most dramatic way cancer raises potassium is through tumor lysis syndrome, or TLS. When large numbers of cancer cells die rapidly, they burst and dump their intracellular contents into the bloodstream. Since the concentration of potassium inside cells is many times higher than in the blood, the sudden release can overwhelm the kidneys’ ability to clear it.3PubMed Central. The tumor lysis syndrome The resulting spike in blood potassium can cause life-threatening heart rhythm problems and is treated as a medical emergency.4PubMed Central. Tumor lysis syndrome in the emergency department: challenges and solutions
TLS most commonly occurs after starting chemotherapy or other cancer-killing treatments, especially for blood cancers that tend to involve large volumes of rapidly dividing cells.2Oncology in Clinical Practice. Potassium imbalances induced by systemic cancer therapy: pathophysiology and potential therapeutic strategies Because doctors know this risk, patients beginning treatment for aggressive leukemias or lymphomas are given preventive fluids and medications ahead of time. The goal is to keep potassium, uric acid, and phosphorus from building up faster than the kidneys can handle. When prevention fails, emergency treatment involves aggressive IV fluids to boost kidney output and, in severe cases, dialysis.4PubMed Central. Tumor lysis syndrome in the emergency department: challenges and solutions
Spontaneous Tumor Lysis Before Treatment Begins
In rare cases, tumor lysis happens spontaneously, before any chemotherapy or treatment has been given. This can occur when a tumor is growing so fast that cells are dying on their own from outstripping their blood supply, or when a very large tumor simply has high turnover.5PubMed Central. Spontaneous Tumor Lysis Syndrome in the Setting of Pancreatic Adenocarcinoma Spontaneous TLS is uncommon enough to warrant published case reports when it happens, and it has been described in both blood cancers and, occasionally, solid tumors like pancreatic cancer.
The significance for someone worried about an unexplained high potassium reading is that spontaneous TLS is one scenario where elevated potassium could theoretically be the lab finding that leads to a cancer diagnosis. But it is genuinely rare. When it does happen, the patient usually already feels very sick with symptoms like nausea, weakness, and confusion, not just an incidental lab value found during a routine checkup.6PubMed Central. Spontaneous Tumor Lysis Syndrome
When Cancer Spreads to the Adrenal Glands
Your two adrenal glands sit on top of your kidneys and produce aldosterone, the hormone that tells the kidneys to hold onto sodium and excrete potassium. If both adrenal glands are damaged or destroyed, aldosterone production drops and potassium accumulates. Several types of cancer, especially lung cancer, have a tendency to spread to the adrenal glands. One case report described a man with metastatic lung cancer who developed severe hyperkalemia because bilateral adrenal metastases wiped out his ability to make aldosterone.7PubMed Central. Severe hyperkalemia and bilateral adrenal metastasis
A systematic review of adrenal insufficiency caused by bilateral adrenal metastases found that every patient studied who had the condition showed hyperkalemia.8Heliyon. Adrenal insufficiency due to bilateral adrenal metastases – A systematic review and meta-analysis These patients also commonly had low blood pressure and low sodium. The pattern of high potassium paired with low sodium and low blood pressure is a classic hallmark of adrenal insufficiency, and doctors who see this combination will look into whether the adrenal glands are functioning properly.
In one documented case, a patient with lung adenocarcinoma developed gradually worsening hyperkalemia, loss of appetite, and fatigue that eventually progressed to impaired consciousness. Testing confirmed adrenal failure from metastatic disease, and the patient improved with hormone replacement therapy.9Internal Medicine. Impaired Consciousness Caused by a Metastatic Adrenal Tumor of Pulmonary Adenocarcinoma The gradual onset in that case is worth noting: adrenal destruction by a growing tumor tends to develop slowly, meaning the hyperkalemia creeps up over weeks or months rather than appearing overnight.
Kidney Injury in Cancer Patients
The kidneys are the main exit route for excess potassium, so anything that impairs kidney function can cause levels to rise. Cancer can damage the kidneys in several ways. Some tumors directly obstruct the urinary tract. Certain chemotherapy drugs are toxic to kidney tissue. Multiple myeloma, a cancer of plasma cells, is particularly known for causing kidney injury because the abnormal proteins it produces can clog and damage the kidney’s filtering structures.10PubMed Central. Acute kidney injury in the patient with cancer
When a cancer patient’s potassium starts climbing, impaired kidney function is one of the first things doctors check for, because it is the most common contributor and because it often has a treatable cause. Even moderate kidney impairment can tip potassium levels high enough to be dangerous if the patient is also taking medications that independently raise potassium, like certain blood pressure drugs or anti-inflammatory painkillers.
Immunotherapy and Adrenal Hormone Disruption
Immune checkpoint inhibitors have transformed cancer treatment over the past decade, but they come with their own set of side effects, some of which can cause high potassium. These drugs work by releasing the brakes on the immune system so it attacks cancer cells more effectively, but sometimes the newly unleashed immune response also attacks the body’s own tissues. The adrenal glands and the pituitary gland, which controls the adrenals, are both vulnerable.
When immunotherapy triggers inflammation of the pituitary (called hypophysitis) or direct damage to the adrenal glands (adrenalitis), the result can be a drop in the hormones that regulate potassium. A case report involving a patient with ureteral cancer on pembrolizumab, a widely used checkpoint inhibitor, described severe hyperkalemia caused by immunotherapy-induced hormone deficiency. The authors emphasized that doctors need to watch for this complication, especially in patients who already have risk factors like kidney dysfunction or diabetes.11PubMed Central. Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit
This is a newer area of concern because checkpoint inhibitors are being prescribed for a growing number of cancer types. The hyperkalemia itself is treatable once recognized, but the danger lies in not connecting the dots quickly enough, since the hormone deficiency can develop weeks to months after starting therapy and may not be the first explanation that comes to mind.
Pseudohyperkalemia and False Alarms
Sometimes the potassium reading itself is wrong. Pseudohyperkalemia refers to a falsely elevated potassium level caused by potassium leaking out of blood cells after the sample is drawn, not while the blood is still circulating in your body. This happens during routine processing of the blood tube, and it is especially common in patients with blood cancers that produce extremely high white blood cell or platelet counts.12PubMed. Pseudohyperkalemia in chronic lymphocytic leukemia: Prevalence, impact, and management challenges
In chronic lymphocytic leukemia, for instance, the white blood cell count can be enormously elevated. When these fragile cells are jostled during blood draw and sample handling, they release their intracellular potassium into the sample tube, making the lab result look dangerously high even though the patient’s actual blood potassium is normal. The clinical significance matters: a doctor who treats pseudohyperkalemia as real and gives aggressive potassium-lowering therapy could actually drive potassium dangerously low.
The standard way to check for pseudohyperkalemia is to compare a regular serum sample with a plasma sample drawn into a heparinized tube, which is processed differently and less prone to this artifact. Any cancer patient with a very high white cell count and unexpected hyperkalemia should have this distinction investigated before treatment decisions are made.13PubMed. Sodium and Potassium Dysregulation in the Patient With Cancer
Does Elevated Potassium Predict Future Cancer in Healthy People?
One study that stands out looked at this question from a different angle. Rather than studying patients who already had cancer, researchers followed a large group of healthy Norwegian men over many years and tracked whether baseline fasting potassium levels predicted who would later develop cancer. They found that the risk of being diagnosed with any type of cancer rose by about 16 percent for each standard-deviation increase in fasting potassium. Men whose potassium was in the hyperkalemic range had an incidence rate about 40 percent higher than men with normal levels, and this association held up even after the researchers excluded cancers diagnosed in the first ten years of follow-up to minimize reverse causation.14PubMed Central. Fasting Serum Levels of Potassium and Sodium in Relation to Long-Term Risk of Cancer in Healthy Men
The finding is intriguing but hard to interpret. An association in one observational study of men does not prove causation, and it does not mean that potassium itself drives cancer growth. It could reflect some shared underlying metabolic process, subclinical kidney changes, dietary patterns, or something else entirely. No public health body currently recommends using potassium levels as a cancer screening tool, and no follow-up study has replicated the finding in a way that would change clinical practice. The result is worth knowing about, but it should not be a source of alarm for someone whose blood work comes back slightly above normal.
Dietary Potassium Tells the Opposite Story
Adding to the complexity, research on dietary potassium intake points in the opposite direction. Studies looking at people who consume more potassium through food have generally found lower, not higher, rates of certain cancers. An analysis of data from two large cohort studies found that women with the highest dietary potassium intake had about an 18 percent lower risk of lung cancer compared with those who consumed the least.15PubMed Central. Association between dietary sodium, potassium intake and lung cancer risk: evidence from the prostate, lung, colorectal and ovarian cancer screening trial and the Women’s Health Initiative A case-control study on breast cancer found that higher total potassium intake was associated with substantially lower odds of the disease, with particularly strong protective associations when the potassium came from fruits and vegetables.16PubMed Central. The predictive role of the total potassium intake and odds of breast cancer: a case-control study
These findings do not actually contradict the blood-level data. What you eat and what shows up in your blood are related but not identical. A diet rich in potassium-containing foods also tends to be rich in fiber, antioxidants, and other compounds that could independently reduce cancer risk. Meanwhile, high blood potassium in a clinical setting reflects problems with how the body handles potassium internally, not how much is coming in from food. The practical takeaway is that eating potassium-rich foods like bananas, beans, and leafy greens is not going to push your blood potassium into a dangerous range if your kidneys are working normally, and may carry its own cancer-related benefits.
How Hyperkalemia Compares to Other Cancer-Related Electrolyte Problems
Electrolyte imbalances are common in cancer patients broadly, and hyperkalemia is just one of several patterns that oncologists watch for. Hypercalcemia, or high calcium, is the most frequently cited electrolyte emergency in malignancy, occurring when certain tumors secrete a hormone-like substance that pulls calcium out of bones and into the blood. Low sodium from a condition called the syndrome of inappropriate antidiuretic hormone secretion is another well-known pattern, particularly in lung cancers.17PubMed Central. An Overview of the Management of Electrolyte Emergencies and Imbalances in Cancer Patients
Compared to hypercalcemia, high potassium is less often the initial presentation that leads to a cancer diagnosis. Hypercalcemia can cause noticeable symptoms like intense thirst, frequent urination, and confusion that bring patients to the doctor. Hyperkalemia, by contrast, tends to be “silent” until it becomes severe enough to affect the heart, at which point the situation is urgent. This is part of why high potassium is less useful as a warning sign: it either does not cause symptoms until it is dangerous, or the symptoms it produces (fatigue, muscle weakness, nausea) are so nonspecific that they could point to dozens of conditions.
When to Actually Worry About a High Potassium Reading
If your bloodwork shows mildly elevated potassium and you feel fine, the most common explanation is a lab artifact. Squeezing the fist during a blood draw, a difficult stick that damages cells, or a sample that sat too long before processing can all bump the reading by a small amount. Your doctor will usually recheck it. Mild elevations also frequently trace to medications, particularly ACE inhibitors, ARBs, potassium-sparing diuretics, and nonsteroidal anti-inflammatory drugs.
Persistent, genuinely elevated potassium with no obvious medication or dietary explanation warrants investigation, but cancer will be low on the list unless other red flags are present. Those red flags include unexplained weight loss, new and unusual fatigue, known adrenal or kidney problems, a very high white blood cell count, or abnormal findings on other blood tests like elevated uric acid and phosphorus (the classic pattern of tumor lysis). If you have already been diagnosed with cancer and your potassium starts rising, that is a conversation to have with your oncologist promptly, since the specific cause determines how aggressively it needs to be treated and whether it signals a change in your disease.
The anxiety that can follow an abnormal lab result is understandable, but context matters enormously here. High potassium sits at the intersection of dozens of possible causes, and cancer accounts for a small fraction of them. For a person with no cancer diagnosis, the finding is far more likely to be a lab error or a medication side effect than the first clue to a hidden malignancy.